Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1177/2324709618765893 http://scihub22266oqcxt.onion/10.1177/2324709618765893 C5871038!5871038!29619395     free     free     free Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 219.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Investig+Med+High+Impact+Case+Rep 2018 ; 6 (ä): ä Nephropedia Template TP {{tp|p=29619395|t=2018. Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment |pdf=|usr=}}{{29619395}} gab.com Text Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment JO: J Investig Med High Impact Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=29619395 #FOAvip Cronkhite-Canada syndrome is a rare syndrome consisting of extensive gastrointestinal polyposis and ectodermal changes including cutaneous hyperpigmentation, alopecia, and onychodystrophy. We report the case of a 45-year-old Caucasian male patient who failed multiple treatments over 2 years including steroids, azathioprine, adalimumab, and cyclosporine. He had recurrent and prolonged hospitalizations because of diarrhea, abdominal pain, weight loss, and malnutrition. Sirolimus was initiated with a significant clinical and endoscopic benefit apparent within, respectively, 2 and 8 weeks. An ongoing remission was achieved and maintained for over 6 months after prednisone tapering. We review the current evidence on treatment of Cronkhite-Canada syndrome and suggest the incorporation of sirolimus in that algorithm. Twit Text FOAVip Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment ????J Investig Med High Impact Case Rep http://www.kidney.de/pget.php?&tw=1&pmid=29619395 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29619395 #FOAvip English Wikipedia <ref>{{Cite pmid|29619395}}</ref> Sirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standard Treatment #MMPMID29619395 Langevin C; Chapdelaine H; Picard JM; Poitras P; Leduc R J Investig Med High Impact Case Rep 2018[Jan]; 6 (ä): ä PMID29619395show ga Cronkhite-Canada syndrome is a rare syndrome consisting of extensive gastrointestinal polyposis and ectodermal changes including cutaneous hyperpigmentation, alopecia, and onychodystrophy. We report the case of a 45-year-old Caucasian male patient who failed multiple treatments over 2 years including steroids, azathioprine, adalimumab, and cyclosporine. He had recurrent and prolonged hospitalizations because of diarrhea, abdominal pain, weight loss, and malnutrition. Sirolimus was initiated with a significant clinical and endoscopic benefit apparent within, respectively, 2 and 8 weeks. An ongoing remission was achieved and maintained for over 6 months after prednisone tapering. We review the current evidence on treatment of Cronkhite-Canada syndrome and suggest the incorporation of sirolimus in that algorithm. äSirolimus in Refractory Cronkhite-Canada Syndrome and Focus on Standar(epmc).pdf DeepDyve Pubget Overpricing